Tag:

inflammation

Type 2
Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure | Cardiovascular Diabetes

by Anna V. Naumova June 29, 2024

by Anna V. Naumova June 29, 2024

Study setting and patients In this double-blind, randomized trial, adult patients with type 2 diabetes received placebo or dapagliflozin 10 mg once daily for 12 months. The study began on …

Today’s Diabetes News, your ultimate destination for up-to-date and insightful information on diabetes, health tips, and living a fulfilling life with diabetes. Our mission is to empower and support individuals with diabetes, their loved ones, and the wider community by providing reliable, relevant, and engaging content that fosters a healthier and happier life.

Interesting Topics

Study questions the need for endotype-specific diets in diabetes management

New study finds garlic has positive effects on cholesterol and blood sugar levels

Balanced Weight Loss and Wellness Promotes Healthy Living – The Tryon Daily Bulletin

Most Viewed Articles

Cluster analysis of patient characteristics, treatment modalities, renal impairments, and inflammatory markers in...

The bitterness of sugar – Economic Times

Everything You Need to Know About Zepbound

Latest Articles

Why office workers should consider wearing compression socks every day – Viasox

Grains, oats are associated with higher risk

Free Diabetes Health Fair in Chambersburg: Screenings, education and more on November 9th

'The Shining' star Shelley Duvall dies from diabetes complications: What does it mean?

Are you sure want to unlock this post?

Unlock left : 0

inflammation

Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure | Cardiovascular Diabetes

Interesting Topics

Most Viewed Articles

Latest Articles

Are you sure want to unlock this post?

Are you sure want to cancel subscription?